# Laurent Peyrin‐Biroulet

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/laurent-peyrin-biroulet/

## Facts

| Field | Value |
| --- | --- |
| Citations | 89,416 |
| Field | Inflammatory Bowel Disease |
| h-index | 138 |
| i10-index | 876 |
| Last Known Institution | Inserm |
| OpenAlex ID | https://openalex.org/A5042884495 |
| ORCID iD | https://orcid.org/0000-0003-2536-6618 |
| Works | 2,068 |

## Researcher papers

- [STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD](https://scholariq.org/papers/stride-ii-an-update-on-the-selecting-therapeutic-targets-in-inflammatory-bowel/)
- [Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target](https://scholariq.org/papers/selecting-therapeutic-targets-in-inflammatory-bowel-disease-stride-determining/)
- [Ulcerative colitis](https://scholariq.org/papers/ulcerative-colitis-2/)
- [Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47](https://scholariq.org/papers/meta-analysis-identifies-29-additional-ulcerative-colitis-risk-loci-increasing/)
- [Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis](https://scholariq.org/papers/ustekinumab-as-induction-and-maintenance-therapy-for-ulcerative-colitis/)
- [Crohn’s disease](https://scholariq.org/papers/crohn-s-disease/)
- [Imaging techniques for assessment of inflammatory bowel disease: Joint ECCO and ESGAR evidence-based consensus guidelines](https://scholariq.org/papers/imaging-techniques-for-assessment-of-inflammatory-bowel-disease-joint-ecco-and/)
- [Development of the Crohnʼs disease digestive damage score, the Lémann score](https://scholariq.org/papers/development-of-the-crohn-s-disease-digestive-damage-score-the-lemann-score/)
- [Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn’s Disease After Ileocolonic Resection](https://scholariq.org/papers/infliximab-reduces-endoscopic-but-not-clinical-recurrence-of-crohn-s-disease/)
- [Deep Remission at 1 Year Prevents Progression of Early Crohn’s Disease](https://scholariq.org/papers/deep-remission-at-1-year-prevents-progression-of-early-crohn-s-disease/)
- [Management of Patients With Crohn’s Disease and Ulcerative Colitis During the Coronavirus Disease-2019 Pandemic: Results of an International Meeting](https://scholariq.org/papers/management-of-patients-with-crohn-s-disease-and-ulcerative-colitis-during-the/)

## Researcher topics

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)
- [Microscopic Colitis](https://scholariq.org/topics/microscopic-colitis/)
- [Autoimmune and Inflammatory Disorders](https://scholariq.org/topics/autoimmune-and-inflammatory-disorders/)
- [Biosimilars and Bioanalytical Methods](https://scholariq.org/topics/biosimilars-and-bioanalytical-methods/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)

## Researcher university

- [Inserm](https://scholariq.org/institutions/inserm/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.